153 related articles for article (PubMed ID: 10853801)
21. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
[TBL] [Abstract][Full Text] [Related]
22. Preoperative localization of parathyroid lesions. Value of 99mTc-MIBI tomography and factors influencing detection.
Ansquer C; Mirallié E; Carlier T; Abbey-Huguenin H; Aubron F; Kraeber-Bodéré F
Nuklearmedizin; 2008; 47(4):158-62. PubMed ID: 18690375
[TBL] [Abstract][Full Text] [Related]
23. Accurate planning of minimally invasive surgery of parathyroid adenomas by means of [(99m)Tc]MIBI SPECT.
Massaro A; Cittadin S; Rampin L; Banti E; Rossi F; Pelizzo MR; Muzzio PC; Rubello D
Minerva Endocrinol; 2007 Mar; 32(1):9-16. PubMed ID: 17353862
[TBL] [Abstract][Full Text] [Related]
24. The key role of 99mTc-MIBI SPECT/CT in the diagnosis of parathyroid adenoma: a case report.
Li Q; Pan J; Luo Q; Wang Y; Bao Y; Jia W
Arch Endocrinol Metab; 2015 Jun; 59(3):265-9. PubMed ID: 26154096
[TBL] [Abstract][Full Text] [Related]
25. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
[TBL] [Abstract][Full Text] [Related]
26. Importance of radio-guided minimally invasive parathyroidectomy using hand-held gamma probe and low (99m)Tc-MIBI dose. Technical considerations and long-term clinical results.
Rubello D; Casara D; Giannini S; Piotto A; De Carlo E; Muzzio PC; Pelizzo MR
Q J Nucl Med; 2003 Jun; 47(2):129-38. PubMed ID: 12865873
[TBL] [Abstract][Full Text] [Related]
27. Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism.
Krausz Y; Bettman L; Guralnik L; Yosilevsky G; Keidar Z; Bar-Shalom R; Even-Sapir E; Chisin R; Israel O
World J Surg; 2006 Jan; 30(1):76-83. PubMed ID: 16369710
[TBL] [Abstract][Full Text] [Related]
28. Dual-phase 99mTc-sestamibi imaging: its utility in parathyroid hyperplasia and use of immediate/delayed image ratios to improve diagnosis of hyperparathyroidism.
Gordon L; Burkhalter W; Mah E
J Nucl Med Technol; 2002 Dec; 30(4):179-84. PubMed ID: 12446751
[TBL] [Abstract][Full Text] [Related]
29. Positive
Dugonjić S; Šišić M; Radulović M; Ajdinović B
Hell J Nucl Med; 2017; 20(1):46-50. PubMed ID: 28315908
[TBL] [Abstract][Full Text] [Related]
30. Sestamibi parathyroid scintigraphy in multigland disease.
Nichols KJ; Tomas MB; Tronco GG; Palestro CJ
Nucl Med Commun; 2012 Jan; 33(1):43-50. PubMed ID: 22001718
[TBL] [Abstract][Full Text] [Related]
31. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).
Taillefer R; Boucher Y; Potvin C; Lambert R
J Nucl Med; 1992 Oct; 33(10):1801-7. PubMed ID: 1328564
[TBL] [Abstract][Full Text] [Related]
32. Ectopic parathyroid adenomas located at the carotid bifurcation: the role of preoperative Tc-99m MIBI scintigraphy and the intraoperative gamma probe procedure in surgical treatment planning.
Rubello D; Piotto A; Pagetta C; Pelizzo M; Casara D
Clin Nucl Med; 2001 Sep; 26(9):774-6. PubMed ID: 11507296
[TBL] [Abstract][Full Text] [Related]
33. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
Gayed IW; Kim EE; Broussard WF; Evans D; Lee J; Broemeling LD; Ochoa BB; Moxley DM; Erwin WD; Podoloff DA
J Nucl Med; 2005 Feb; 46(2):248-52. PubMed ID: 15695783
[TBL] [Abstract][Full Text] [Related]
34. Preoperative localization of parathyroid adenomas using 99mTc-MIBI scintigraphy.
Moka D; Voth E; Dietlein M; Larena-Avellaneda A; Schicha H
Am J Med; 2000 Jun; 108(9):733-6. PubMed ID: 10924651
[No Abstract] [Full Text] [Related]
35. [Scintigraphy of the parathyroid glands with 99mTc-MIBI].
Grünwald F; Späth G; Menzel C; Pavics L; Sudhop T; Liesegang P; Klingmüller D; Schomburg A; Biersack HJ
Med Klin (Munich); 1995 Aug; 90(8):450-5. PubMed ID: 7565402
[TBL] [Abstract][Full Text] [Related]
36. [Scintigraphy of parathyroid adenomas with 99mTc-sestamibi in an endemic goiter area].
Joseph K; Welcke U; Höffken H; Koppelberg T; Rothmund M
Nuklearmedizin; 1994 Jun; 33(3):93-8. PubMed ID: 8090632
[TBL] [Abstract][Full Text] [Related]
37. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
38. Preoperative technetium Tc 99m sestamibi SPECT imaging in the management of primary hyperparathyroidism in patients with concomitant multinodular goiter.
Lorberboym M; Ezri T; Schachter PP
Arch Surg; 2005 Jul; 140(7):656-60. PubMed ID: 16027330
[TBL] [Abstract][Full Text] [Related]
39. Comparison of SPET/CT, SPET and planar imaging using 99mTc-MIBI as independent techniques to support minimally invasive parathyroidectomy in primary hyperparathyroidism: A meta-analysis.
Wei WJ; Shen CT; Song HJ; Qiu ZL; Luo QY
Hell J Nucl Med; 2015; 18(2):127-35. PubMed ID: 26187212
[TBL] [Abstract][Full Text] [Related]
40. Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism.
Martínez-Rodríguez I; Martínez-Amador N; de Arcocha-Torres M; Quirce R; Ortega-Nava F; Ibáñez-Bravo S; Lavado-Pérez C; Bravo-Ferrer Z; Carril JM
Rev Esp Med Nucl Imagen Mol; 2014; 33(2):93-8. PubMed ID: 24125595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
